Nautilus Biotechnology, Inc.
NAUT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $6,353 | $5,705 | $3,416 | $2,842 |
| Gross Profit | -$6,353 | -$5,705 | -$3,416 | -$2,842 |
| % Margin | – | – | – | – |
| R&D Expenses | $50,477 | $47,251 | $36,455 | $26,510 |
| G&A Expenses | $30,999 | $28,901 | $0 | $0 |
| SG&A Expenses | $30,999 | $28,901 | $23,747 | $21,146 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$6,353 | -$5,705 | $0 | $0 |
| Operating Expenses | $75,123 | $70,447 | $60,202 | $47,656 |
| Operating Income | -$81,476 | -$76,152 | -$63,618 | -$50,498 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $10,696 | $12,477 | $5,694 | $183 |
| Pre-Tax Income | -$70,780 | -$63,675 | -$57,924 | -$50,315 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$70,780 | -$63,675 | -$57,924 | -$50,315 |
| % Margin | – | – | – | – |
| EPS | -0.56 | -0.51 | -0.46 | -0.6 |
| % Growth | -9.8% | -10.9% | 23.3% | – |
| EPS Diluted | -0.56 | -0.51 | -0.46 | -0.6 |
| Weighted Avg Shares Out | 125,427 | 124,919 | 124,589 | 84,464 |
| Weighted Avg Shares Out Dil | 125,427 | 124,919 | 124,589 | 84,464 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,780 | $12,550 | $5,816 | $329 |
| Interest Expense | $0 | $0 | $5,816 | $0 |
| Depreciation & Amortization | $6,353 | $1,849 | $3,416 | $2,842 |
| EBITDA | -$64,427 | -$74,303 | -$54,508 | -$47,473 |
| % Margin | – | – | – | – |